This program is supported by @genomecanada.ca and @genomebc.bsky.social through the Genomic Applications Partnership Program. Learn more about the program in the announcement.

Through this effort, the team will validate BugSeq’s bioinformatic platform to improve patient outcomes and strengthen Canadian biosecurity and pandemic preparedness.

BugSeq is delighted to partner with the University of British Columbia to improve detection, surveillance and early identification of emerging respiratory pathogens across Canada.

Two case reports on the identification and management of hypervirulent Klebsiella pneumoniae isolated in Nebraska, USA | ASM Case Reports Klebsiella pneumoniae is commonly found in the human gastrointestinal tract and can act as an opportunistic nosocomial pathogen, causing a range of infections such as pneumonia, wounds, and infections...

Hypervirulent Klebsiella pneumoniae is an emerging concern in clinical microbiology. Read how BugSeq was used to characterize the first cases of hypervirulent K. pneumoniae in Nebraska: doi.org/10.1128/asmc...

In case you missed it, the recording of the BugSeq + @nanoporetech.com webinar is now available on demand! Discover how Dr. Georgios Kitsios used BugSeq for respiratory metagenomics in the @upmc.com ICU:

nanoporetech.com/resource-cen...

Clinical interpretation and reporting of next-generation sequencing assays is challenging. Check out our recent blog post to learn about how BugSeq leverages machine learning and configurable thresholds to implement evidence-based reporting for your NGS assay. 🧬

→ docs.bugseq.com/blog/2026/01...

Global lessons from metagenomics for future critical care and pathogen surveillance Join this webinar and learn key technical considerations, optimisations, and training insights for implementing Oxford Nanopore metagenomic workflows in research and surveillance settings.

Don't miss out! Join us on January 14th for an insightful webinar with Dr. Kitsios of @upmc.com. Learn how BugSeq delivers rapid, actionable, and highly accurate results for respiratory #metagenomics in critical care settings.

nanoporetech.com/about/events...

2025 was an amazing year for sequencing in microbiology! Check out some of our favorite publications from the past year. 🦠

docs.bugseq.com/blog/2025/12...

🚨 BugSeq now supports both EUCAST (new) and CLSI (already supported) breakpoints for the prediction of #AMR. This expansion ensures greater accuracy and global applicability in determining resistance. Get in touch for early access to EUCAST breakpoints on your account.

Check out this recent article by Dr. Jose Alexander, AdventHealth, on the power of BugSeq and how it is enabling NGS-based pathogen detection and resistance characterization in their healthcare system!

www.linkedin.com/pulse/amr-ge...

At #AMPath2025? Here is one more reason why you need to drop by booth 447 to discuss bioinformatics with our team of experts!

🚨 New Publication 🚨
Check out this paper from @mskcancercenter.bsky.social, where BugSeq empowers the center's infection control team to launch an active C. auris surveillance program. WGS informs infection control interventions → doi.org/10.1016/j.jm...
#InfectionPrevention #Cauris

Meet BugSeq at #IDWeek2025 - Booth 1329!
See how our bioinformatics platform empowers clinical microbiology labs and drives clinically validated assays with customizable reporting thresholds.

Clinical and public health labs need solutions that make sequencing analysis easier. In our upcoming webinar, learn how BugSeq supports pathogen identification, AMR detection, and outbreak surveillance without complex bioinformatics pipelines.

Register here: event.on24.com/wcc/r/506648...

Ever wonder how BugSeq is used to identify bacteria, characterize #AMR and track outbreaks in hospitals and the community? Tune in on Sep 29 to hear from Wes Hottel, Bioinformatics Scientist, State Hygienic Laboratory, The University of Iowa: event.on24.com/wcc/r/506648...

Register for our upcoming webinar on September 29: event.on24.com/wcc/r/506648...

C. difficile is the most frequent cause of infectious diarrhea in hospitals and long-term care facilities. Locher et al. used BugSeq to evaluate transmission within @vchhealthcare.bsky.social (doi.org/10.1016/j.mi...). Want to learn more?

NGS has improved pathogen surveillance, but complex bioinformatics pipelines can hold many labs back. Join our upcoming webinar to learn how @bugseq.com makes advanced microbial ID, AMR detection, and outbreak tracking accessible to every lab.

Register here: event.on24.com/wcc/r/506648...

🚨 New blog - Bringing Precision Medicine to the ICU: Insights from BugSeq Grant Recipient Dr. Georgios Kitsios (@upmc.com). Read how Dr. Kitsios is leveraging @nanoporetech.com metagenomics to revolutionize diagnosis and management of ventilator-associated pneumonia: docs.bugseq.com/blog/2025/08...

Want to learn more about our AMR prediction? See our recent blog post: docs.bugseq.com/blog/2025/07...

Amaral et al. found a discordance between BIOFIRE BCID2 and #AMR phenotype. Read how BugSeq’s curated database enabled frameshift detection in a CTX-M and accurate phenotype prediction: doi.org/10.1016/j.di...

🚨 Headed to #ADLM2025? Come say hi to the BugSeq team at Booth 1064!

We’re showcasing the future of infectious disease assays with rapid, accurate, and interpretable genomic solutions.

Let’s talk metagenomics, AMR, and more 🧬👩‍🔬

#ADLM2025 #microbiology #genomics #AMR @myadlm.bsky.social

Read it here 👉 docs.bugseq.com/blog/2025/07...

#AMR #Genomics #Bioinformatics #MachineLearning #AST #gAST #microbiology

New blog post: Enabling Phenotypic AMR Prediction from NGS Data

We explore the strengths and pitfalls of current methods—and why BugSeq’s approach, combining expert-augmented ML with a curated database, delivers more accurate, interpretable phenotypic predictions from NGS data.

The first half of 2025 marked a significant leap forward for the BugSeq Bioinformatics platform, delivering powerful new capabilities to tackle the most pressing challenges in infectious disease. Read some of our highlights in our recent blog post: docs.bugseq.com/blog/2025/06...

Can’t make the poster session? Visit us at Booth 911 all weekend to learn more about how BugSeq can serve your bioinformatic needs!

We detail how a combination of long-read 16S sequencing, high-accuracy bioinformatic tools harnessing a curated reference database, and reporting that is aligned with clinical standards for amplicon-based pathogen detection can be an effective tool for pathogen detection in clinical specimens.

At #ASMMicrobe today? Check out the Clinical Public Health Microbiology poster session (CPHM-Saturday-289) between 10:30-11:30am or 4:00-5:00pm to learn more about BugSeq’s updated, clinically-oriented workflow for 16S analysis from @nanoporetech.com sequence data.

Attending #ASMicrobe this weekend? Visit the BugSeq booth (#911) to learn more about BugSeq’s comprehensive bioinformatics platform for applied microbiology and infectious disease applications!